We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Automated Systems Evaluated for Diagnosis of Urinary Infections

By LabMedica International staff writers
Posted on 13 Dec 2011
Rapid diagnostic of urinary tract infections (UTI) is necessary to provide early information about the presence of bacteria and the indication to administer an antibiotic therapy.

Different rapid automated systems have been evaluated as diagnostic tools for UTIs and compared with a semiquantitative plate culture-reference method in a university hospital with a highly complex patient population. More...


At the University Hospital of Tübingen (Germany) scientists analyzed 2,230 urine samples using three different rapid automated systems for diagnosis of UTIs. In detail, 950 samples were tested using the UroQuick system, 751 samples were analyzed using the BACSYS-40i system, and 572 samples were tested using the UF-1000i system. The three systems were consecutively tested, each over at least two months. Urine samples were collected from patients attending the University Hospital. The results were compared with a semiquantitative plate culture-reference method incubated overnight at 37 °C.

In comparison to the results obtained by culture techniques, the UroQuick (Alifax; Padova, Italy) showed a sensitivity of 73.0% as compared to positive samples and a specificity of 92.8% as compared to negative samples. Similarly, the BACSYS-40i (Sysmex; Kobe, Japan) revealed a sensitivity of 78.8% and a specificity of 61.8%, and Sysmex's other system, the UF-1000i had a sensitivity of 80.9% and specificity of 78.0%. Contaminated urine samples were excluded from the analysis.

Additionally, sensitivity and specificity for the most common UTI-causing microorganisms were analyzed and showed that sensitivity and specificity correlate with the colony forming units of microorganisms in the urine, with a sensitivity of nearly 90% for Gram-negative rods, typical for community acquired UTIs, but a very low sensitivity for Gram-positive bacteria and yeasts. The hands-on time using the automated systems was significantly reduced to approximately 30 seconds per sample, as compared to that of the culture method. However, the main saving in time is obtained for negative samples. In order to gain information about antibiotic susceptibility, the positive tested samples have to be analyzed by culture techniques.

The authors concluded that the currently available automated systems might possibly be helpful to analyze a typical UTI in an ambulant patient population but not for rapid diagnosis of UTIs in a complex population of hospitalized patients. The study was published on November 11, 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University Hospital of Tübingen
Alifax
Sysmex



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.